Ischemic disease of lower extremity
Conditions
Interventions
Traditional drug group:medication
ropivacaine group:adminstrated ropivacaine
Mixed Dexmedetomidine group:adminstrated ropivacaine with dexmedetomidine
Sponsors
Tianjin Medical University General Hospital
Eligibility
Sex/Gender
All
Age
20 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. patients with lower limb ischemic disease treated by vascular surgery; 2. ASA grade II -III; 3. patients aged 65-85 years old, sex is not limited; 4. patients have fully understandthe nature of the study, voluntary participation in this experiment andsigned informed consent.
Exclusion criteria
Exclusion criteria: 1. known to the study of the drug ingredients allergies andallergic constitution; 2. puncture site infection ulcer; 3. coronary heart disease; bronchial asthma; severe hypertension; heart andlung disease andliver andkidney function is not complete; serious blood system dysfunction; 4. obesity (BMI>30); 5. The history of nervous system disease, drug addiction andalcoholism; 6. Clinical trials of other drugs in the past 4 weeks; 7. compliance is poor, can not be completed by the research program; 8. for any reason, the researchers believe that there is any situation that is not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale; | — |
Countries
China
Contacts
Public ContactWang Guo-lin
Outcome results
None listed